Cannabinoids and ethanol can activate the same reward pathways, which could suggest endocannabinoid involvement in the rewarding effects of ethanol. The high ethanol preference of young (6 -10 weeks) C57BL͞6J mice is reduced by the cannabinoid receptor 1 (CB1) antagonist SR141716A to levels observed in their CB1 knockout littermates or in old (26 -48 weeks) wild-type mice, in both of which ethanol preference is unaffected by SR141716A. Similarly, SR141716A inhibits food intake in food-restricted young, but not old, wild-type mice. There are no age-dependent differences in the tissue levels of the endocannabinoids anandamide and 2-arachidonoylglycerol or the density of CB1 in the hypothalamus, limbic forebrain, amygdala, and cerebellum. A lcohol is known to differentially affect neurotransmission in the brain, and pharmacological modulation of certain neurotransmitter systems has been found to reduce alcohol preference in rodents and alcohol consumption by alcoholics. Neurotransmitters implicated in controlling ethanol (EtOH) preference, such as norepinephrine (1), dopamine (2), serotonin (3, 4), endogenous opioids (5), and neuropeptide Y (6), have been also found to play important roles in the control of appetite and food intake (7), lending credence to the notion that alcoholism is an appetitive disorder.
A
lcohol is known to differentially affect neurotransmission in the brain, and pharmacological modulation of certain neurotransmitter systems has been found to reduce alcohol preference in rodents and alcohol consumption by alcoholics. Neurotransmitters implicated in controlling ethanol (EtOH) preference, such as norepinephrine (1) , dopamine (2) , serotonin (3, 4) , endogenous opioids (5) , and neuropeptide Y (6), have been also found to play important roles in the control of appetite and food intake (7) , lending credence to the notion that alcoholism is an appetitive disorder.
Endogenous cannabinoids are recently discovered lipid mediators (8) that produce their effects via interaction with specific cannabinoid receptors (CBs) such as the brain type, or CB1 (9) , and CB2 expressed predominantly in cells of the immune system (10) . Endogenous cannabinoids have been implicated in a growing number of biological functions, including the control of appetite and food intake. We recently reported that foodrestrained mice deficient in CB1 (CB1 Ϫ/Ϫ mice) eat less than their wild-type littermates (CB1 ϩ/ϩ mice), and the selective CB1 antagonist SR141716A reduces food intake in CB1 ϩ/ϩ but not in CB1 Ϫ/Ϫ mice (11) . These findings indicate that endogenous cannabinoids are positive modulators of food intake, providing a rational explanation of the well known appetite stimulating effect of marijuana. SR141716A has also been reported to reduce voluntary EtOH intake in rodent models of EtOH drinking behavior (12) (13) (14) (15) . Although this could suggest a role for endogenous cannabinoids in the control of EtOH preference, the well known inverse agonist property of SR141716A (16) makes such a conclusion tenuous. In the present study, we examined the possible role of endogenous cannabinoids in EtOH preference using CB1 ϩ/ϩ and CB1 Ϫ/Ϫ mice developed on a C57BL͞6J background (17) , a strain known to have high preference for EtOH (18) . The results indicate that endogenous cannabinoids acting at CB1 can be implicated in the high EtOH preference of young C57BL͞6J mice, and reduced CB1 signaling in the limbic forebrain may be involved in the age-dependent decline in both EtOH preference and food intake.
Materials and Methods

Animals. CB1
Ϫ/Ϫ and CB1 ϩ/ϩ mice have been developed as described (17) . Briefly, the CB1 gene was mutated in MPI2 embryonic stem cells, and chimeric and heterozygous animals were backcrossed to C57BL͞6J mice. CB1 Ϫ/Ϫ and CB1 ϩ/ϩ littermates were obtained by interbreeding heterozygous mice, and genotype was established by a PCR-based assay using DNA extracted from the tail. All animals were housed under a 12-h light͞dark cycle and had access to food and water ad libitum, except when stated otherwise. Animals used were defined as either young (6-10 weeks of age) or old (26-48 weeks of age) at the time of the experiment.
remaining forebrain tissue, which contained the nucleus accumbens and the anterior cingulate cortex, was referred to as limbic forebrain. The hypothalamus was then isolated by a second coronal cut through the mamillary bodies, two parallel sagittal cuts at the lateral edge of the optic tracts, and a horizontal cut across the top of the third ventricle. Finally, the lower parietal regions containing the pyriform cortex and the amygdala were dissected free. The four samples were frozen on dry ice and weighed. Brain tissue samples from individual mice, weighing 30-60 mg, were homogenized in 0.5 ml of an ice-cold solution of methanol/Tris buffer (50 mM, pH 8.0), 1:1, containing 7 ng of d4-anandamide, synthesized as described (19) . To each homogenate, 2 ml of ice-cold chloroform͞methanol (1:1) and 0.5 ml of 50 mM Tris buffer, pH 8.0, was added. The homogenate was centrifuged at 4°C (500 ϫ g for 2 min), the chloroform phase was recovered and transferred to a borosilicate tube, and the water phase was extracted two more times with ice-cold chloroform. The combined extract was evaporated to dryness at 32°C under a stream of nitrogen. The dried residue was reconstituted in 110 l of chloroform, and 2 ml of ice-cold acetone was added. The precipitated proteins were removed by centrifugation (1,800 ϫ g, 10 min), and the clear supernatant was removed and evaporated to dryness. The dry residues were reconstituted in 50 l of ice-cold methanol, of which 35 l was used for analysis by liquid chromatography͞in line mass spectrometry, by using an Agilent 1100 series LC-MSD, equipped with a thermostated autosampler and column compartment. Liquid chromatographic separation of endocannabinoids was achieved by using a guard column (Discovery HS C18, 2 cm ϫ 4.0 mm, 3 m, 120A) and analytical column (Discovery HS C18, 7.5 cm ϫ 4.6 mm, 3 m) at 32°C with a mobile phase of methanol͞water͞acetic acid (85:15:0.1, vol͞vol͞vol) at a flow of 1 ml͞min for 12 min followed by 8 min of methanol͞acetic acid (100:0.1, vol͞vol). The MSD (model LS) was set for atmospheric pressure chemical ionization, positive polarity, and selected ion monitoring to monitor ions m͞z 348 for AEA, 352 for d4-AEA, and 379 for 2-arachidonoylglycerol (2-AG). The spray chamber settings were as follows: vaporizer, 400°C; gas temperature, 350°C; drying gas, 5.0 liters͞min; and nitrogen was used as the nebulizing gas with a pressure of 60 psig. Calibration curves were produced by using synthetic anandamide and 2-AG (Cayman Chemical, Ann Arbor, MI). The amounts of AEA and 2-AG in the samples were determined by using inverse linear regression of standard curves. Values are expressed as fmol or pmol per mg wet tissue.
Radioligand Binding. The density of CB1 was assessed as described (20) . Briefly, the cerebellum, limbic forebrain, amygdala, and hypothalamus were dissected from young and old CB1 ϩ/ϩ mice. The tissue was homogenized in 5 ml of ice-cold buffer A (320 mM sucrose͞50 mM Tris⅐HCl͞2 mM EDTA͞5 mM MgCl 2 , pH 7.4). The homogenate was centrifuged at 1,000 ϫ g for 10 min at 4°C. The supernatant was saved, and the pellet was resuspended in fresh buffer A and washed twice more with subsequent centrifugations. The combined supernatants were centrifuged at 40,000 ϫ g for 30 min. The pellet was resuspended in 2 ml of buffer B (50 mM Tris⅐HCl͞1 mM EDTA͞3 mM MgCl 2 , pH 7.4) to yield a protein concentration of 1 mg͞ml. Binding was initiated by the addition of 50 g of membrane protein to silanized tubes containing a saturating concentration (2 nM) of [ 3 H]SR141716A (52.0 Ci͞mmol, Amersham Pharmacia) and buffer C (buffer B supplemented with 5 mg͞ml BSA) to bring the total volume to 1 ml. Nonspecific binding was established in the presence of 1 M unlabeled SR141716A. Triplicate aliquots were incubated at 30°C for 1 h, followed by the addition of 2 ml of ice-cold buffer D (50 mM Tris⅐HCl͞1 mg/ml BSA, pH 7.4) and vacuum filtration through GF͞B filters presoaked in buffer D. Retained radioactivity was quantified by liquid scintillation spectrometry. The use of a single saturating concentration of the radioligand instead of full saturation isotherm was necessitated due to the small size of tissue and the limited number of homozygous animals available. In pilot experiments, the K d of [ 3 H]SR141716A binding determined from saturation isotherms was 0.15-0.2 nM using membranes prepared from whole mouse brain, in agreement with a published report (21) . (21) . Briefly, 50 g of membrane protein was incubated in 0.5 ml of TME-Na buffer (50 mM Tris⅐HCl͞0.2 mM EGTA͞3 mM MgCl 2 ͞100 mM NaCl, pH 7. Triplicate aliquots were incubated at 30°C for 1 h, and the reaction was terminated by the addition of 2 ml of ice-cold wash buffer (50 mM Tris⅐HCl, pH 7.4), followed by vacuum filtration through GF͞B filters, and the retained radioactivity was quantified by liquid scintillation spectrometry.
Membrane͞G Protein Reconstitution Assay. These assays were performed as described (22) . Briefly, brain tissue is homogenized in 5 ml of ice-cold lysis buffer (5 mM Tris⅐HCl, pH 7.5͞5 mM EGTA͞5 mM EDTA͞0.1 mM PMSF͞1 g/ml pepstatin͞1 g/ml aprotinin). The lysate is centrifuged at 17,000 ϫ g for 15 min, and the pellet is resuspended in 0.5 ml of buffer A (50 mM Tris⅐HCl, pH 7.4͞0.6 mM EDTA͞5 mM MgCl 2 ) and incubated with 100 ng͞ml pertussis toxin at 4°C for 2 h. Membranes are solubilized with 1 ml of 1% sodium cholate for 30 min at 4°C. The material is centrifuged at 100,000 ϫ g for 1 h, and the supernatant is used for the assay. Western Blotting. Tissue levels of G protein subunits or RGS proteins were quantified by Western immunoblotting as described (20) . All antibodies were purchased from Santa Cruz Biotechnology. The T-19 antibody is specific for G i ␣ 2 and non-crossreactive with G i ␣ 1 or G i ␣ 3 ; the C-10 antibody is reactive with G i ␣ 1 , G i ␣ 2 , and G i ␣ 3 and non-crossreactive with other Gi␣ subunit proteins. The K-20 antibody is specific for G o ␣, and the T-20 antibody is broadly reactive with G␤ 1 , G␤ 2 , G␤ 3 , and G␤ 4 . N-16 and C-20 are specific antibodies for RGS4 and RGS10, respectively.
-methyl-1H-pyrazole-3-carboxamide HCl) was synthesized and provided by the National Institute on Drug Abuse; anandamide (arachidonyl ethanolamide) was from Sigma. HU-210 (⌬ 9 -tetrahydrocannabinol dimethylheptyl) was synthesized and kindly provided by Dr. Raphael Mechoulam. SR141716A, anandamide, and HU-210 were dissolved in alkmulphor͞EtOH͞saline (1:1:18) and injected i.p. in volumes of 5-10 l. Alkmulphor is a vegetable oil (Rhodia, Cranbury, NJ).
Statistical Analyses. Comparison of the means from multiple treatment groups was done by using ANOVA followed by Duncan's post hoc test. For comparing pre-and posttreatment values in the same animals, the paired t test was used. Values with a P Ͻ 0.05 were considered statistically significant.
Results
EtOH Preference Is Higher in Young Than in Old CB1 ؉/؉ or Young CB1 ؊/؊ Mice. EtOH preference and intake were determined in a two-bottle, free-choice paradigm by using a 20% or 10% EtOH solution in water vs. water. Due to an interruption in our breeding program, only old animals were available for the first series of experiments. By using the 20% EtOH vs. water paradigm, EtOH preference and intake were similar in old CB1 ϩ/ϩ mice and their CB1 Ϫ/Ϫ littermates and were unaffected by pretreatment of mice with vehicle or 3 g͞g SR141716A in either group (Fig. 1 Right) .
When new litters became available, similar experiments were done by using animals 6-10 weeks of age. EtOH preference in the young CB1 ϩ/ϩ mice ( Fig. 1 Left) was higher than in the old mice, and both the high preference (Upper) and the absolute amount of EtOH consumed (Lower) were significantly reduced by SR141716A, which did not affect total fluid intake. The difference was significant compared either to untreated control or vehicle-treated mice in the same group. In contrast, in CB1 Ϫ/Ϫ mice, EtOH preference and intake were similar in young and old animals and were unaffected by SR141716A pretreatment (Fig.  1) . Similar results were obtained by using the 10% EtOH vs. water paradigm; in CB1 ϩ/ϩ mice, EtOH intake (g͞kg mouse) was reduced by SR141716A in young (13.3 Ϯ 1.9 vs. 5.1 Ϯ 1.7, vehicle vs. SR, P Ͻ 0.01) but not in old animals (8.2 Ϯ 1.7 vs. 6.2 Ϯ 1.0), whereas in CB1 Ϫ/Ϫ mice, EtOH intake was unaffected by SR141716A in both young (9.9 Ϯ 2.1 vs. 10.7 Ϯ 2.3, vehicle vs. SR) and old (8.1 Ϯ 1.7 vs. 8.0 Ϯ 0.9) mice.
Serum EtOH Levels in Free-Drinking Mice. To test whether mice drink sufficient alcohol to produce psychotropic effects, serum alcohol levels were measured in six young CB1 ϩ/ϩ mice with free access to 20% EtOH or water. Because mice drink during the dark phase, the animals were killed 2 h after the beginning of the dark phase. Serum alcohol levels ranged from 3.0 to 137.0 mg͞dl and were highly correlated (r ϭ 0.86) with the amount of EtOH consumed during the preceding 2-h period (0.450-6.2 g͞kg). Three of the six mice had serum EtOH levels Ͼ100 mg͞dl (Ͼ22 mM).
Food Intake Declines with Age in CB1 ؉/؉ Mice. The results of a recent study indicate that endocannabinoids acting at CB1 are involved in the control of food intake in C57BL͞6J mice (11) . Because food intake is known to decline with age (23), we tested whether this may also be related to the loss of CB1 involvement. As illustrated in Fig. 2 , food intake in food-restricted mice appeared higher in young than in old CB1 ϩ/ϩ mice, and it was inhibited by SR141716A only in the young animals.
Brain Endocannabinoid Levels Are Similar in Old and Young Mice. To test whether age-dependent differences in endocannabinoid levels may account for or accompany the disappearance of SR141716A-sensitive EtOH intake in older CB1 ϩ/ϩ mice, tissue levels of anandamide and 2-AG were analyzed in four brain regions of young and old CB1 ϩ/ϩ mice. No significant agedependent differences were found in any of the regions studied for either of the two endocannabinoids. Anandamide levels To further explore the possible mechanism underlying the decreased coupling of CB1, the level of expression of G i and G o protein subunits was quantified by Western immunoblotting in membranes prepared from the limbic forebrain of young and old CB1 ϩ/ϩ mice. By using antibodies against G i ␣ 1-3 , G i ␣ 2 , G i ␤ 1-4 , and G o ␣ in preparations from four young and four old mice, no significant age-dependent differences were found, as quantified by densitometry (not shown). Next, we analyzed receptor coupling in a signal reconstitution assay where the receptor has access to the same population of G proteins. CB1 coupling to endogenous G i ͞G o was eliminated by pertussis toxin pretreatment of the membrane preparations, and signal transfer was restored by reconstitution of the cell membranes with functional bovine G protein. When HU-210-stimulated [ 35 S]GTP[␥S] binding was compared in membranes from young and old CB1 ϩ/ϩ mice by using this signal-restoration assay, similar levels of binding were detected in the cerebellum, whereas in the limbic forebrain binding was significantly lower in preparations from old compared with young mice (Fig. 5) . We also quantified two of the more common RGS proteins, which are accessory factors operating at the receptor͞G protein interface. Western blotting using antibodies against RGS4 and RGS10 revealed no significant difference in the level of these two proteins, as tested in membranes from the limbic forebrain of four young and four old CB1 ϩ/ϩ mice (not shown).
Possible Link Between Reduced EtOH Preference and CB1 Signaling in
Old Mice. To examine a possible cause and effect relationship between reduced EtOH preference and CB1 signaling in old mice, we tested whether treatment of old CB1 ϩ/ϩ mice with a CB1 agonist can increase voluntary EtOH intake in the 10% EtOH vs. water paradigm. We first treated mice with 20 ng͞g HU-210 (i.p.), which caused marked behavioral inhibition including hypomotility, associated with a drastic reduction in both food and total fluid intake (not shown). Because the behavioral effects of HU-210 are known to interfere with ingestive behavior (24), we next tested anandamide at a dose (1 g͞g s.c.) that is subthreshold for causing the cannabinoid-like tetrad effects including hypomotility (25) , but is maximally effective in increasing food intake (26) . Treatment of six old CB1 ϩ/ϩ mice with anandamide did not influence their total fluid intake, but 24-h EtOH intake increased by 46 Ϯ 13% (P Ͻ 0.05) from 8.7 to 12.6 g͞kg body weight per day, whereas combined treatment of six other old CB1 ϩ/ϩ mice with 3 g͞g SR141716A plus 1 g͞g anandamide did not affect 24-h EtOH intake (Ϫ17 Ϯ 21%, from 8.0 to 6.9 g͞kg per day).
Discussion
The present findings provide unequivocal evidence for the role of endocannabinoids and CB1 in alcohol-drinking behavior in rodents and suggest that the age-dependent decline in EtOH preference may be linked to a parallel decline in CB1 signaling. They further suggest that the same mechanism may be involved in the age-dependent decline in food intake.
The significantly higher EtOH preference and intake of young wild-type mice compared with their CB1 Ϫ/Ϫ littermates, and the ability of SR141716A to reduce EtOH drinking in wild-type but not in CB1 Ϫ/Ϫ mice, clearly indicates that activation of CB1 contributes to the high preference for EtOH of C57BL͞6J mice. These findings are in agreement with recent reports that SR141716A can reduce EtOH intake in rodent models of alcohol drinking (see Introduction) and indicate that the effect of SR141716A is due to CB1 antagonism rather than inverse agonist activity or a nonspecific effect. They are also in agreement with the reported ability of CP-55,940, a highly potent CB1 agonist, to increase the motivation of rats to drink alcohol (27) . The inability of SR141716A to inhibit alcohol drinking in older wild-type or in CB1 Ϫ/Ϫ mice is unlikely to be due to a floor effect, as these animals still consumed significant amounts of alcohol. Rather, this finding suggests that endocannabinoids are involved in the drive to drink only over a certain threshold. This is similar to their involvement in the hunger-induced increase in food intake, but not in basal levels of food ingestion in sated animals (11) .
CB1 are the most abundant neurotransmitter receptors in the brain. Although they are also present in some peripheral tissues, CB1-mediated behavioral effects, such as the modification of ingestive behaviors, are believed to be triggered in the brain. Interestingly, in young wild-type mice, SR141716A reduced EtOH preference and intake to levels below those seen in knockout mice (see Fig. 1 ). This could suggest that compensatory changes in other neurotransmitter systems in knockouts may have offset some of the effects of lack of cannabinoid signaling.
Although unexpected, the observed age-dependent decline in EtOH preference in wild-type mice parallels observations in humans, in that only some of the teenage binge drinkers become alcoholics as adults, and that the onset of alcoholism declines with age (28) . Interestingly, a study published almost 40 years ago demonstrated that in BALB͞c mice, which are known to avoid alcohol, alcohol preference measured in a paradigm similar to that used in the present study was as high as 40% in the first 10 weeks of life, after which preference declined to around 10% (29) . Thus, the age dependence of EtOH preference manifests not only longitudinally in a given strain but also across strains with genetically based differences in EtOH preference.
Unlike wild-type mice, young CB1 Ϫ/Ϫ mice displayed low EtOH preference, which remained unchanged as the animals got older. Furthermore, the age-dependent decline in EtOH preference in wild-type mice was associated with a loss of the ability of SR141716A pretreatment to further reduce EtOH preference and intake. These findings strongly suggest that the decline in EtOH preference is related to a loss of cannabinoid signaling in a relevant brain area. As a further indication for a cause and effect relationship between these two phenomena, treatment of old wild-type mice with a low dose of anandamide was able to cause a small but significant increase in voluntary EtOH intake, and this effect could be prevented by simultaneous treatment with the CB1 antagonist SR141716A.
Age-dependent differences in the brain levels of endocannabinoids and their precursors (30) , as well as of CB1 (31) and CB1-mediated effects on synaptic transmission (32), have been reported. However, in CB1 ϩ/ϩ mice, no age-dependent changes in anandamide and 2-AG levels or CB1 densities could be detected in four brain regions. Three of these, the hypothalamus, the limbic forebrain that includes the nucleus accumbens, and the nucleus amygdala comprise the most important structures involved in the central neural control of appetite and food intake. Although changes limited to a smaller subregion may have gone undetected, these findings suggest that a decrease in endogenous mediators or in the cellular density of their receptors is unlikely to account for the loss of cannabinoid-mediated EtOH preference in old mice.
In the absence of measurable changes in ligand or receptor levels, the observed striking, selective reduction in agoniststimulated GTP [␥S] labeling in the limbic forebrain of old mice could suggest that a localized decline in the coupling of CB1 to G proteins may account for the reduced alcohol preference. A variety of mechanisms may influence receptor͞G protein coupling. These include, although are not limited to, changes in receptor trafficking, posttranslational covalent modification of G proteins (33) or receptors, and the presence of accessory proteins such as RGS proteins (34) or receptor activitymodifying proteins (35) . Although the molecular mechanism(s) underlying the region-specific change in CB1-stimulated GTP[␥S] labeling remain to be determined, the present findings allow some conclusions. The level of G o ͞G i proteins in the brain is in excess of most G protein-coupled receptors (36) . However, CB1 is expressed in the brain at such a high level that a reduction in the expression of G o ͞G i protein subunits may become limiting for CB1 signaling in some brain regions. However, this is unlikely in view of the unchanged levels of G i and G o subunit proteins in young and old mouse brain, and also of the finding that the selective reduction in GTP[␥S] labeling in the limbic forebrain of old mice is retained in a receptor͞G protein reconstitution assay. Alternatively, covalent modification of CB1 such as protein kinase C-induced phosphorylation, which has been shown to impair CB1 signaling (37) , could result in reduced GTP [␥S] labeling.
A part of the limbic forebrain, the nucleus accumbens, is a major site for mediating the rewarding properties of both alcohol (38) and cannabinoids (39, 40) , and it has also been implicated in the regulation of appetite (41) . These effects are thought to be mediated through increases in dopamine release in the nucleus accumbens (42) , which has been documented both for cannabinoids (43) and EtOH (44) . Furthermore, a selective decrease in glutamate-induced dopamine release in the accumbens but not in the striatum of aged rats has been reported (45) . Thus, this region of the brain is a plausible site for the agedependent interaction of EtOH and endocannabinoids.
The well documented anorexia of old age (23) is analogous to the decline in food intake we observed in old CB1 ϩ/ϩ mice, which also became insensitive to inhibition by SR141716A (Fig. 2) . This suggests that the nucleus accumbens or another structure in the limbic forebrain is a likely site for the parallel, age-dependent decline in food as well as EtOH intake. Of interest, the results of a recent study indicate that GTP[␥S] binding stimulated by the cannabinoid agonist CP-55,940 was markedly lower in brain membranes prepared from alcohol avoiding DBA͞2 mice than in preparations from the alcohol preferring C57BL͞6J mice (46) . These and other observations, indicating that chronic exposure of mice to EtOH down-regulates CB1-stimulated GTP [␥S] binding (47) , further suggest that CB1 signaling is both a neuronal target of EtOH and a determinant of EtOH preference. The molecular mechanism(s) of the region-specific change in GTP[␥S] labeling and its possible behavioral consequences remain to be determined.
